• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

癌症领域的新技术及其评估。临床外科医生的观点。

New technologies in cancer and their assessment. The clinical surgeon's point of view.

作者信息

Escrig Sos Javier, Martínez Ramos David

机构信息

Department of Surgery, General Hospital of Castellón, Castellón de la Plana, Spain.

出版信息

Clin Transl Oncol. 2008 Nov;10(11):713-8. doi: 10.1007/s12094-008-0277-7.

DOI:10.1007/s12094-008-0277-7
PMID:19015067
Abstract

The assessment of new technologies in oncological surgery is an important part of clinical research in cancer. The special characteristics of surgeons and surgical techniques determine particular problems. In this review, from the perspective of efficacy, effectiveness and efficiency, problematic specific aspects are discussed for diagnostic and therapeutic technologies.

摘要

肿瘤外科新技术评估是癌症临床研究的重要组成部分。外科医生和手术技术的特殊特性决定了特定的问题。在本综述中，从疗效、有效性和效率的角度，对诊断和治疗技术中存在问题的具体方面进行了讨论。

相似文献

1
New technologies in cancer and their assessment. The clinical surgeon's point of view.癌症领域的新技术及其评估。临床外科医生的观点。
Clin Transl Oncol. 2008 Nov;10(11):713-8. doi: 10.1007/s12094-008-0277-7.
2
Lessons learned from a failed multi-institutional randomized controlled study.从一项失败的多机构随机对照研究中吸取的教训。
J Pediatr Surg. 2002 Mar;37(3):431-6. doi: 10.1053/jpsu.2002.30853.
3
Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT.经括约肌型肛瘘切开术与肛瘘栓治疗经括约肌型肛瘘的随机对照试验（FIAT RCT）
Health Technol Assess. 2019 May;23(21):1-76. doi: 10.3310/hta23210.
4
The Introduction of Innovations in Neurovascular Care: Patient Selection and Randomized Allocation.神经血管护理创新的介绍：患者选择与随机分配
World Neurosurg. 2018 Oct;118:e99-e104. doi: 10.1016/j.wneu.2018.06.127. Epub 2018 Jun 23.
5
Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.评价随机对照试验及其他研究中的以患者为中心的结局指标：从过去的经验中吸取教训，为未来提供信息。
Clin Cancer Res. 2010 Dec 15;16(24):5963-71. doi: 10.1158/1078-0432.CCR-10-1962.
6
Comparative effectiveness research: opportunities in surgical oncology.比较疗效研究：外科肿瘤学的机遇。
Semin Radiat Oncol. 2014 Jan;24(1):43-8. doi: 10.1016/j.semradonc.2013.09.003.
7
Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.实用随机临床试验：一项关于加强对具有早期显著活性迹象的新型癌症疗法评估的提议。
Ann Oncol. 2016 Jul;27(7):1342-8. doi: 10.1093/annonc/mdw143. Epub 2016 Mar 30.
8
The Placement of Aortic Transcatheter Valve (PARTNER) trial: the surgeon's perspective: celebration and concern.主动脉经导管瓣膜置入（PARTNER）试验：外科医生的观点：庆祝与担忧
Circulation. 2012 Jun 26;125(25):3237-9. doi: 10.1161/CIRCULATIONAHA.112.093096.
9
The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.外科医生和医院的病例数量对结直肠癌手术后生存率和局部复发的影响。
Surgery. 2006 Mar;139(3):296-304. doi: 10.1016/j.surg.2005.08.023.
10
The Cardiothoracic Surgical Trials Network: Implications for clinical practice.
J Thorac Cardiovasc Surg. 2017 Dec;154(6):1938-1956. doi: 10.1016/j.jtcvs.2017.08.016. Epub 2017 Aug 24.

本文引用的文献

1
Bias in surgical research.外科研究中的偏倚
Ann Surg. 2008 Aug;248(2):180-8. doi: 10.1097/SLA.0b013e318176bf4b.
2
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.流行病学观察性研究报告强化声明（STROBE）：解释与详述
Ann Intern Med. 2007 Oct 16;147(8):W163-94. doi: 10.7326/0003-4819-147-8-200710160-00010-w1.
3
Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.腹腔镜手术治疗结直肠癌的临床疗效与成本效益：系统评价与经济学评估
Health Technol Assess. 2006 Nov;10(45):1-141, iii-iv. doi: 10.3310/hta10450.
4
Digital technologies and quality improvement in cancer surgery.数字技术与癌症手术的质量改进
Eur J Surg Oncol. 2005 Aug;31(6):689-94. doi: 10.1016/j.ejso.2005.02.031.
5
Better reporting of harms in randomized trials: an extension of the CONSORT statement.随机试验中不良事件的更好报告：CONSORT声明的扩展
Ann Intern Med. 2004 Nov 16;141(10):781-8. doi: 10.7326/0003-4819-141-10-200411160-00009.
6
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.胃癌放化疗前瞻性随机试验中的手术治疗差异：治疗不足的影响。
Ann Surg Oncol. 2002 Apr;9(3):278-86. doi: 10.1007/BF02573066.
7
[From evidence-based medicine to medicine-based evidence].[从循证医学到基于医学的证据]
An Esp Pediatr. 2001 Nov;55(5):429-39.
8
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.胃癌或胃食管交界腺癌术后同步放化疗与单纯手术的比较。
N Engl J Med. 2001 Sep 6;345(10):725-30. doi: 10.1056/NEJMoa010187.
9
Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours.通过使用置信水平、临床意义曲线和风险效益轮廓来改进临床研究的解读。
Lancet. 2001 Apr 28;357(9265):1349-53. doi: 10.1016/S0140-6736(00)04522-0.
10
The revised CONSORT statement for reporting randomized trials: explanation and elaboration.报告随机试验的修订版CONSORT声明：解释与详述。
Ann Intern Med. 2001 Apr 17;134(8):663-94. doi: 10.7326/0003-4819-134-8-200104170-00012.